Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
Article 2022 en
Authors
LM
Lorena Martínez-Montesinos
JR
José Miguel Rivera‐Caravaca
SA
Stefan Agewall
Abstract
1 min read
In this "real world" AF cohort, polypharmacy was highly prevalent and conditioned worse prognosis due to its association with bleeding and thromboembolic events.
Davide Antonio Mei, Marco Proietti, Giulio Francesco Romiti, Tommaso Bucci, Bernadette Corica, Alena Shantsila, Hung‐Fat Tse, Giuseppe Boriani, Tze-Fan Chao, Professor Gregory Lip
Tommaso Bucci, Katarzyna Nabrdalik, Alena Shantsila, Giulio Francesco Romiti, Wee‐Siong Teo, Hyung Wook Park, Wataru Shimizu, Hung‐Fat Tse, Marco Proietti, Tze‐Fan Chao, Professor Gregory Lip
Monika Kozieł, Stefan Simović, Nikola Pavlović, Aleksandar Kocijančić, Vilma Paparisto, Ljilja Musić, Elina Trendafilova, Anca Rodica Dan, Zumreta Kušljugić, Gheorghe‐Andrei Dan, Professor Gregory Lip, Tatjana Potpara
Discussion(0)
No comments yet. Be the first to comment.